Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Media Resources

Press Releases

  • All News
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering

August 7, 2019

Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark

July 9, 2019

Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine

June 26, 2019

Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®

June 4, 2019

Titan Pharmaceuticals Reports First Quarter 2019 Financial Results

May 15, 2019

Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®

May 13, 2019

Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow

May 8, 2019

Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine®

April 29, 2019

/C O R R E C T I O N -- Titan Pharmaceuticals, Inc./

April 1, 2019

Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results

April 1, 2019

  • « Previous
  • 1
  • 2
  • 3
  • Next »
© 2025 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter